Is Ipamorelin Legal? Global Status Guide
Category: Growth Hormone · Tracked in 158 countries
29
Legal1
Research Only121
Grey Area3
Prescription4
BannedCan You Buy Ipamorelin?
Whether you can buy Ipamorelin depends on your country. It is legal to purchase in 29 countries, including Jamaica, Dominican Republic, Bahamas, Trinidad and Tobago, Barbados, Cayman Islands, Aruba, Curacao, and 21 more. A prescription is required in 3 countries, including Australia, United Arab Emirates, New Zealand. It falls into a legal grey area in 121 countries (United States, Canada, Germany, France, Netherlands, Sweden, Norway, Denmark, and 113 more), where it may be available for research but not for human use. It is banned in 4 countries: Cuba, China, Singapore, Saudi Arabia.
Traveling with Ipamorelin
Traveling internationally with Ipamorelin requires understanding local laws at your destination. Do not carry Ipamorelin into countries where it is banned (Cuba, China, Singapore, Saudi Arabia) — you could face serious legal consequences. In countries requiring a prescription (Australia, United Arab Emirates, New Zealand), carry a valid prescription or doctor's letter. Always declare pharmaceutical products at customs and check the latest regulations before traveling.
Need to calculate your Ipamorelin dosage? Use the Ipamorelin reconstitution calculator on peptide.locker
Ipamorelin Legal Status by Country (158)
| Country | Status | Rx Required | Schedule | Detail |
|---|---|---|---|---|
| Anguilla | Legal | No | Not Scheduled | Not scheduled. De facto unregulated. |
| Antigua and Barbuda | Legal | No | Not Scheduled | Not specifically regulated. |
| Aruba | Legal | No | Unregistered | Not specifically regulated. |
| Bahamas | Legal | No | Unregistered | Not specifically regulated. |
| Barbados | Legal | No | Unregistered | Not specifically regulated. |
| Bosnia and Herzegovina | Legal | No | Not Registered | Non-EU. Not registered. GHRP. WADA banned. Research-label available. |
| British Virgin Islands | Legal | No | Not Scheduled | Not scheduled. De facto unregulated. |
| Cayman Islands | Legal | No | Unregistered | Not specifically regulated. |
| Costa Rica | Legal | No | Unregistered | Not specifically regulated. |
| Curacao | Legal | No | Unregistered | Not specifically regulated. |
| Dominica | Legal | No | Not Scheduled | Not specifically regulated. |
| Dominican Republic | Legal | No | Unregistered | Not specifically regulated. |
| Georgia | Legal | No | Not Registered | Non-EU. Not registered. GHRP. WADA banned. Research-label available. Essentially unregulated. |
| Grenada | Legal | No | Not Scheduled | Not specifically regulated. |
| Jamaica | Legal | No | Unregistered | Not specifically regulated. |
| Montenegro | Legal | No | Not Registered | Non-EU. Not registered. GHRP. WADA banned. Research-label available. |
| Montserrat | Legal | No | Not Scheduled | Not scheduled. De facto unregulated. |
| North Macedonia | Legal | No | Not Registered | Non-EU. Not registered. GHRP. WADA banned. Research-label available. |
| Papua New Guinea | Legal | No | Not Scheduled | Not specifically regulated. Same status as CJC-1295 in PNG. |
| Samoa | Legal | No | Not Scheduled | Not regulated. Same status as CJC-1295. |
| Serbia | Legal | No | Not Registered | Non-EU. Not registered. GHRP. WADA banned. Research-label available. Very low enforcement. |
| St Kitts and Nevis | Legal | No | Not Scheduled | Not specifically regulated. |
| St Lucia | Legal | No | Not Scheduled | Not specifically regulated. |
| St Vincent and the Grenadines | Legal | No | Not Scheduled | Not specifically regulated. |
| Tonga | Legal | No | Not Scheduled | Not regulated. Same status as CJC-1295. |
| Trinidad and Tobago | Legal | No | Unregistered | Not specifically regulated. |
| Turks and Caicos | Legal | No | Not Scheduled | Not scheduled. De facto unregulated. |
| Ukraine | Legal | No | Not Registered | Non-EU. Not registered. GHRP. WADA banned. Research-label available. |
| Vanuatu | Legal | No | Not Scheduled | Not regulated. Same as CJC-1295. |
| United Kingdom | Research Only | No | Not Scheduled | Not controlled. Legal for research. Same framework as CJC-1295. |
| Algeria | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Import restrictions apply. |
| Andorra | Grey Area | No | Not Scheduled | Not authorized. Same as CJC-1295. |
| Angola | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Argentina | Grey Area | No | Unregistered | Not specifically regulated. |
| Austria | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Bahrain | Grey Area | No | Unregistered | Not specifically regulated. |
| Bangladesh | Grey Area | No | Not Scheduled | Not registered. Same as CJC-1295. |
| Belgium | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Belize | Grey Area | No | Unregistered | Not specifically regulated. |
| Bolivia | Grey Area | No | Unregistered | Not specifically regulated. |
| Bonaire | Grey Area | No | Not Scheduled | Not scheduled. De facto unregulated. |
| Botswana | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Brazil | Grey Area | No | Unregistered | Not specifically regulated. |
| Brunei | Grey Area | No | Not Scheduled | Not registered. Same status as CJC-1295. |
| Bulgaria | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Cambodia | Grey Area | No | Unregistered | Available through local peptide suppliers. |
| Cameroon | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Canada | Grey Area | No | Not Scheduled (CDSA) | Named in Health Canada seizure notices. No DIN. Unauthorized drug. |
| Cape Verde | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Chile | Grey Area | No | Unregistered | Not specifically regulated. |
| Colombia | Grey Area | No | Unregistered | Not specifically regulated. |
| Croatia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Cyprus | Grey Area | No | Not Scheduled | No marketing authorization in EU. Unauthorized medicinal product. |
| Czech Republic | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Democratic Republic of Congo | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Denmark | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Ecuador | Grey Area | No | Unregistered | Not specifically regulated. |
| Egypt | Grey Area | No | Unregistered | Not specifically regulated. |
| El Salvador | Grey Area | No | Unregistered | Not specifically regulated. |
| Estonia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Ethiopia | Grey Area | No | Unregistered | Not specifically regulated. No domestic market for GH secretagogues. |
| Fiji | Grey Area | No | Unregistered | Not registered. Not specifically regulated. |
| Finland | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| France | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| French Guiana | Grey Area | No | Unauthorized Medicine | Not approved. French framework. |
| Germany | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Ghana | Grey Area | No | Unregistered | Not specifically regulated. |
| Greece | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Guatemala | Grey Area | No | Unregistered | Not specifically regulated. |
| Guyana | Grey Area | No | Unregistered | Not specifically regulated. |
| Honduras | Grey Area | No | Unregistered | Not specifically regulated. |
| Hong Kong | Grey Area | No | Unregistered | Not specifically regulated. |
| Hungary | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Iceland | Grey Area | No | WADA S2 (peptide hormones); unauthorized medicine | WADA S2 classified. Postal import prohibited. Same restrictions as BPC-157/CJC-1295. |
| India | Grey Area | No | Unregistered | Available from Indian suppliers. |
| Indonesia | Grey Area | No | Unregistered | Not specifically regulated. |
| Iran | Grey Area | No | Not Scheduled | Not registered. Same as CJC-1295. |
| Iraq | Grey Area | No | Not Scheduled | Not registered. Same as CJC-1295. |
| Ireland | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Israel | Grey Area | No | Unregistered | Not specifically regulated. |
| Italy | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Ivory Coast | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Japan | Grey Area | No | Unapproved Drug | Unapproved. Same strict framework. |
| Jordan | Grey Area | No | Unregistered | Not specifically regulated. |
| Kenya | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Kuwait | Grey Area | No | Unregistered | Not specifically regulated. |
| Laos | Grey Area | No | Unregistered | Not registered. Not specifically regulated. |
| Latvia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Lebanon | Grey Area | No | Not Scheduled | Not registered. Same as CJC-1295. |
| Libya | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Liechtenstein | Grey Area | No | Not Scheduled | No marketing authorization. Unauthorized in EEA. |
| Lithuania | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Luxembourg | Grey Area | No | Not Scheduled | No marketing authorization. Unauthorized in EU. |
| Madagascar | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Malawi | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Malaysia | Grey Area | No | Unregistered | Not specifically regulated. |
| Maldives | Grey Area | No | Unregistered | Not registered. Not specifically regulated. |
| Malta | Grey Area | No | Unauthorized Medicine | Not authorized. Cannot be legally sold or imported for human use in EU framework. |
| Mauritius | Grey Area | No | Unregistered | Not specifically regulated. |
| Mexico | Grey Area | No | Unregistered | Available at peptide clinics. Paired with CJC-1295. |
| Monaco | Grey Area | No | Not Scheduled | No marketing authorization. Unauthorized in France/EU. |
| Morocco | Grey Area | No | Unregistered | No AMM. Not specifically regulated. No domestic market. |
| Mozambique | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Myanmar | Grey Area | No | Unregistered | Available through drug shops. No enforcement. |
| Namibia | Grey Area | No | Unregistered | Not registered. No domestic market. |
| Nepal | Grey Area | No | Unregistered | Not registered. Not specifically regulated. |
| Netherlands | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Nicaragua | Grey Area | No | Unregistered | Not specifically regulated. |
| Nigeria | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Norway | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Oman | Grey Area | No | Unregistered | Not specifically regulated. |
| Pakistan | Grey Area | No | Not Scheduled | Not registered. Same as CJC-1295. |
| Panama | Grey Area | No | Unregistered | Available at anti-aging/wellness clinics. Paired with CJC-1295. |
| Paraguay | Grey Area | No | Unregistered | Not specifically regulated. |
| Peru | Grey Area | No | Unregistered | Not specifically regulated. |
| Philippines | Grey Area | No | Unregistered | Not specifically regulated. |
| Poland | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Portugal | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Qatar | Grey Area | No | Unregistered | Not specifically regulated. |
| Romania | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Russia | Grey Area | No | Unregistered | Available from suppliers. |
| Rwanda | Grey Area | No | Unregistered | Not registered. No domestic market. |
| Saba | Grey Area | No | Not Scheduled | Not scheduled. De facto unregulated. |
| Saint Barthelemy | Grey Area | No | Unauthorized Medicine | Not approved. French framework. |
| Saint Martin (French) | Grey Area | No | Unauthorized Medicine | Not approved. French framework. |
| Senegal | Grey Area | No | Unregistered | Not registered. No domestic market. |
| Seychelles | Grey Area | No | Unregistered | Not registered. Not specifically regulated. |
| Sint Eustatius | Grey Area | No | Not Scheduled | Not scheduled. De facto unregulated. |
| Sint Maarten | Grey Area | No | Not Scheduled | Not scheduled. De facto unregulated. |
| Slovakia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Slovenia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| South Africa | Grey Area | No | Unregulated | Not specifically scheduled. Available from SA research vendors. Offered at peptide therapy clinics alongside CJC-1295. SAHPRA has not individually scheduled GHRPs. HGH itself is Schedule 5 but fragments/secretagogues are not. |
| South Korea | Grey Area | No | Unregistered | Not specifically regulated. |
| Spain | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Sri Lanka | Grey Area | No | Unregistered | Not registered. Not approved by any reference authority. |
| Suriname | Grey Area | No | Unregistered | Not specifically regulated. |
| Sweden | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Switzerland | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. |
| Taiwan | Grey Area | No | Unregistered | Not specifically regulated. |
| Tanzania | Grey Area | No | Unregistered | Not specifically regulated. |
| Thailand | Grey Area | No | Unregistered | Available at wellness clinics. Paired with CJC-1295. |
| Tunisia | Grey Area | No | Unregistered | No MA. Not specifically regulated. |
| Turkey | Grey Area | No | Unregistered | Not specifically regulated. |
| Uganda | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| United States | Grey Area | No | Not Scheduled | Same status as CJC-1295. Removed from Category 2 list Sept 2024. Under PCAC review. Cannot be legally compounded pending outcome. |
| Uruguay | Grey Area | No | Unregistered | Not specifically regulated. |
| US Virgin Islands | Grey Area | No | Not Scheduled | Same as US. Removed from Category 2 Sept 2024. Under PCAC review. |
| Venezuela | Grey Area | No | Unregistered | Not specifically regulated. |
| Vietnam | Grey Area | No | Unregistered | Not specifically regulated. |
| Zambia | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Zimbabwe | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Australia | Prescription | Yes | Schedule 4 + Appendix D Item 5 | Individually named in Schedule 4 + Appendix D since 1 June 2015. |
| New Zealand | Prescription | Yes | Unapproved (Rx Required) | Prescription medicine. Not approved. |
| United Arab Emirates | Prescription | Yes | Clinic Prescribed | Available at anti-aging clinics. Prescription required. |
| China | Banned | No | Unapproved Drug | Unauthorized. No consumer access. |
| Cuba | Banned | No | State Controlled | State pharmaceutical monopoly via CECMED/BioCubaFarma. No private purchase/import permitted. |
| Saudi Arabia | Banned | No | Unauthorized | Unauthorized. Do not import. |
| Singapore | Banned | No | Unapproved Health Product | Unapproved. Do not import. |
Data is researcher-verified but not legal advice. Regulations change frequently. Always verify with local authorities before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.